Postsurgical submits ODD form for hemophilic arthropathy (PTI-101) to the US FDA Postsurgical Therapeutics
Postsurgical and UPEX-MED complete PK and Efficacy for their hemophilic arthropathy program Postsurgical Therapeutics
Postsurgical announces partnership with UPEX-MED for its pain therapeutics program Postsurgical Therapeutics